Jinshi Asia Pharmaceutical (300434.SZ) issued a profit forecast increase, expecting net profit attributable to shareholders for the first three quarters to rise 32.35% to 63.41% year-on-year.

Zhito Finance APP News: Jinshi Asia Pharmaceutical (300434.SZ) has released its earnings forecast for the first three quarters of 2026, expecting a net profit attributable to shareholders of the listed company of RMB 128 million to RMB 158 million, a year-on-year increase of 32.35% to 63.41%.